These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 11163470

  • 1. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae.
    Briles DE, Hollingshead SK, Nabors GS, Paton JC, Brooks-Walter A.
    Vaccine; 2000 Dec 08; 19 Suppl 1():S87-95. PubMed ID: 11163470
    [Abstract] [Full Text] [Related]

  • 2. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae.
    Briles DE, Ades E, Paton JC, Sampson JS, Carlone GM, Huebner RC, Virolainen A, Swiatlo E, Hollingshead SK.
    Infect Immun; 2000 Feb 08; 68(2):796-800. PubMed ID: 10639448
    [Abstract] [Full Text] [Related]

  • 3. Polysaccharide-based pneumococcal vaccines in the prevention of acute otitis media.
    Eskola J.
    Vaccine; 2000 Dec 08; 19 Suppl 1():S78-82. PubMed ID: 11163468
    [Abstract] [Full Text] [Related]

  • 4. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children.
    Simell B, Korkeila M, Pursiainen H, Kilpi TM, Käyhty H.
    J Infect Dis; 2001 Mar 15; 183(6):887-96. PubMed ID: 11237805
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
    Xu JH, Dai WJ, Chen B, Fan XY.
    Scand J Immunol; 2015 Mar 15; 81(3):177-85. PubMed ID: 25565478
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
    Lu J, Sun T, Wang D, Dong Y, Xu M, Hou H, Kong FT, Liang C, Gu T, Chen P, Sun S, Lv X, Jiang C, Kong W, Wu Y.
    Immunol Invest; 2015 Mar 15; 44(5):482-96. PubMed ID: 26107747
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. New vaccines for the prevention of pneumococcal infections.
    Käyhty H, Eskola J.
    Emerg Infect Dis; 1996 Mar 15; 2(4):289-98. PubMed ID: 8969245
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.
    da Silva MA, Converso TR, Gonçalves VM, Leite LCC, Tanizaki MM, Barazzone GC.
    Clin Vaccine Immunol; 2017 Aug 15; 24(8):. PubMed ID: 28637805
    [Abstract] [Full Text] [Related]

  • 14. Pneumococcal otitis media and pneumococcal vaccines, a historical perspective.
    Austrian R.
    Vaccine; 2000 Dec 08; 19 Suppl 1():S71-7. PubMed ID: 11163467
    [Abstract] [Full Text] [Related]

  • 15. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
    Gor DO, Ding X, Briles DE, Jacobs MR, Greenspan NS.
    Infect Immun; 2005 Mar 08; 73(3):1304-12. PubMed ID: 15731027
    [Abstract] [Full Text] [Related]

  • 16. Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age.
    Prymula R, Kriz P, Kaliskova E, Pascal T, Poolman J, Schuerman L.
    Vaccine; 2009 Dec 10; 28(1):71-8. PubMed ID: 19818722
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France.
    Cohen R, Levy C, Bonnet E, Grondin S, Desvignes V, Lecuyer A, Fritzell B, Varon E.
    Vaccine; 2010 Aug 23; 28(37):6114-21. PubMed ID: 19490958
    [Abstract] [Full Text] [Related]

  • 19. Passive immunization for the prevention of otitis media.
    Englund JA, Glezen WP.
    Vaccine; 2000 Dec 08; 19 Suppl 1():S116-21. PubMed ID: 11163474
    [Abstract] [Full Text] [Related]

  • 20. Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized study.
    Hammitt LL, Campbell JC, Borys D, Weatherholtz RC, Reid R, Goklish N, Moulton LH, Traskine M, Song Y, Swinnen K, Santosham M, O'Brien KL.
    Vaccine; 2019 Dec 03; 37(51):7482-7492. PubMed ID: 31629570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.